Castle Biosciences
(NASDAQ:CSTL)
$22.15
0.87[4.09%]
At close: Mar 28
$22.15
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$25.00
Consensus Price Target1
$34.27

Castle Biosciences Stock (NASDAQ:CSTL), Analyst Ratings, Price Targets, Predictions

Castle Biosciences Inc has a consensus price target of $34.27, established from looking at the 31 latest analyst ratings. The last 3 analyst ratings were released from Keybanc, Scotiabank, and Guggenheim on March 1, 2024, March 1, 2024, and December 14, 2023. With an average price target of $30 between Keybanc, Scotiabank, and Guggenheim, there's an implied 35.44% upside for Castle Biosciences Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Dec 23
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Keybanc
Scotiabank
Guggenheim
Lake Street
Stephens & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Castle Biosciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/01/2024CSTLBuy Now
Castle Biosciences
$22.1526.41%Keybanc
Paul Knight
$25 → $28MaintainsOverweightGet Alert
03/01/2024CSTLBuy Now
Castle Biosciences
$22.1567.04%Scotiabank
Sung Ji Nam
$33 → $37MaintainsSector OutperformGet Alert
12/14/2023CSTLBuy Now
Castle Biosciences
$22.1512.87%Guggenheim
Subbu Nambi
→ $25Initiates → BuyGet Alert
08/04/2023CSTLBuy Now
Castle Biosciences
$22.1512.87%Keybanc
Paul Knight
$37 → $25MaintainsOverweightGet Alert
07/07/2023CSTLBuy Now
Castle Biosciences
$22.1544.47%Lake Street
Thomas Flaten
→ $32ReiteratesBuy → BuyGet Alert
07/06/2023CSTLBuy Now
Castle Biosciences
$22.1567.04%Stephens & Co.
Mason Carrico
→ $37ReiteratesOverweight → OverweightGet Alert
06/15/2023CSTLBuy Now
Castle Biosciences
$22.1535.44%BTIG
Mark Massaro
$38 → $30MaintainsBuyGet Alert
06/07/2023CSTLBuy Now
Castle Biosciences
$22.1548.98%Scotiabank
Sung Ji Nam
$54 → $33MaintainsSector OutperformGet Alert
06/06/2023CSTLBuy Now
Castle Biosciences
$22.1580.59%Canaccord Genuity
Kyle Mikson
$60 → $40MaintainsBuyGet Alert
06/05/2023CSTLBuy Now
Castle Biosciences
$22.1558.01%SVB Securities
Puneet Souda
$50 → $35MaintainsOutperformGet Alert
06/05/2023CSTLBuy Now
Castle Biosciences
$22.1544.47%Lake Street
Thomas Flaten
$41 → $32MaintainsBuyGet Alert
06/05/2023CSTLBuy Now
Castle Biosciences
$22.1512.87%Baird
Catherine Ramsey
$35 → $25MaintainsOutperformGet Alert
05/08/2023CSTLBuy Now
Castle Biosciences
$22.1585.1%Stephens & Co.
Mason Carrico
→ $41Reiterates → OverweightGet Alert
05/05/2023CSTLBuy Now
Castle Biosciences
$22.1567.04%Keybanc
Paul Knight
$40 → $37MaintainsOverweightGet Alert
05/04/2023CSTLBuy Now
Castle Biosciences
$22.1585.1%Stephens & Co.
Mason Carrico
→ $41Reiterates → OverweightGet Alert
05/04/2023CSTLBuy Now
Castle Biosciences
$22.1558.01%Baird
Catherine Ramsey
$38 → $35MaintainsOutperformGet Alert
03/02/2023CSTLBuy Now
Castle Biosciences
$22.1585.1%Stephens & Co.
Mason Carrico
→ $41Reiterates → OverweightGet Alert
03/01/2023CSTLBuy Now
Castle Biosciences
$22.1571.56%Baird
Catherine Schulte
$42 → $38MaintainsOutperformGet Alert
01/05/2023CSTLBuy Now
Castle Biosciences
$22.15143.79%Scotiabank
Sung Ji Nam
→ $54Initiates → Sector OutperformGet Alert

FAQ

Q

What is the target price for Castle Biosciences (CSTL)?

A

The latest price target for Castle Biosciences (NASDAQ: CSTL) was reported by Keybanc on March 1, 2024. The analyst firm set a price target for $28.00 expecting CSTL to rise to within 12 months (a possible 26.41% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Castle Biosciences (CSTL)?

A

The latest analyst rating for Castle Biosciences (NASDAQ: CSTL) was provided by Keybanc, and Castle Biosciences maintained their overweight rating.

Q

When was the last upgrade for Castle Biosciences (CSTL)?

A

There is no last upgrade for Castle Biosciences.

Q

When was the last downgrade for Castle Biosciences (CSTL)?

A

There is no last downgrade for Castle Biosciences.

Q

When is the next analyst rating going to be posted or updated for Castle Biosciences (CSTL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Castle Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Castle Biosciences was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.

Q

Is the Analyst Rating Castle Biosciences (CSTL) correct?

A

While ratings are subjective and will change, the latest Castle Biosciences (CSTL) rating was a maintained with a price target of $25.00 to $28.00. The current price Castle Biosciences (CSTL) is trading at is $22.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch